Ratings
0
Nobody has rated this yet. Be the first!
Works
5
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.
Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus
Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer
An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers
Novel germline MSH2 mutation in lynch syndrome patient surviving multiple cancers
